BlackRock’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.6M | Sell |
|
|||||
|
2025
Q1 | $94.9M | Buy |
|
|||||
|
2024
Q4 | $145M | Buy |
|
|||||
|
2024
Q3 | $161M | Buy |
|
|||||
|
2024
Q2 | $142M | Buy |
|
|||||
|
2024
Q1 | $67.3M | Sell |
|
|||||
|
2023
Q4 | $47.9M | Buy |
|
|||||
|
2023
Q3 | $35.5M | Sell |
|
|||||
|
2023
Q2 | $45.1M | Buy |
|
|||||
|
2023
Q1 | $38.1M | Buy |
|
|||||
|
2022
Q4 | $45.5M | Buy |
|
|||||
|
2022
Q3 | $48.5M | Buy |
|
|||||
|
2022
Q2 | $42.5M | Buy |
|
|||||
|
2022
Q1 | $35.4M | Sell |
|
|||||
|
2021
Q4 | $73.8M | Buy |
|
|||||
|
2021
Q3 | $74.4M | Buy |
|
|||||
|
2021
Q2 | $55.4M | Buy |
|
|||||
|
2021
Q1 | $56.5M | Buy |
|
|||||
|
2020
Q4 | $38.5M | Buy |
|
|||||
|
2020
Q3 | $23.4M | Buy |
|